Mary Duskin
Family Medicine · Moultrie, GANPI 1982124285
Payments from drug & device makers
Across 236 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$620
- GSK$480
- AbbVie$349
- Pfizer$318
- Dexcom, Inc.$310
- AstraZeneca$299
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,119100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 32 | $620 |
| GSK | 29 | $480 |
| AbbVie(2 entities) | 21 | $349 |
| Pfizer | 18 | $318 |
| Dexcom, Inc. | 22 | $310 |
| AstraZeneca | 15 | $299 |
| Bayer | 10 | $212 |
| Otsuka America Pharmaceutical, Inc. | 9 | $182 |
| Amgen | 11 | $177 |
| Boehringer Ingelheim | 7 | $142 |
| Lilly USA, LLC | 9 | $133 |
| Merck | 7 | $107 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $83 |
| Astellas Pharma US Inc | 4 | $76 |
| Exact Sciences | 4 | $65 |
| Novartis | 3 | $64 |
| Corium, LLC | 3 | $62 |
| Ironshore Pharmaceuticals Inc. | 3 | $57 |
| Sanofi Pasteur Inc. | 3 | $44 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $44 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Shield Therapeutics Inc | 2 | $39 |
| Almatica Pharma LLC | 2 | $32 |
| Xeris Pharmaceuticals, Inc. | 2 | $26 |
| Phathom Pharmaceuticals, Inc. | 2 | $22 |
| Amicus Therapeutics, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Organogenesis Inc. | 1 | $19 |
| Corcept Therapeutics | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Smith+Nephew | 1 | $14 |
| Melinta Therapeutics, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$119
How this compares
$4,119 in reported general payments places this provider in the 80th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 190 | $165,203 |
| MounjaroTirzepatide | 133 | $152,411 |
| OzempicSemaglutide | 98 | $110,161 |
| TrulicityDulaglutide | 43 | $44,482 |
| EliquisApixaban | 46 | $35,725 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 58 | $35,408 |
| FarxigaDapagliflozin Propanediol | 37 | $31,028 |
| RybelsusSemaglutide | 29 | $29,207 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $26,199 |
| XareltoRivaroxaban | 25 | $25,766 |
| LinzessLinaclotide | 27 | $21,334 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 92 | $12,876 |
| MyrbetriqMirabegron | 20 | $12,798 |
| Breo ElliptaFluticasone/Vilanterol | 27 | $11,934 |
| Diclofenac Sodium | 42 | $8,868 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $133 | $196,893176 claims |
| Boehringer IngelheimJardiance | $142 | $165,203190 claims |
| Novo NordiskOzempic, Rybelsus | $620 | $139,368127 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $299 | $70,802113 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $480 | $38,13241 claims |
| PfizerEliquis | $318 | $35,72546 claims |
| AbbVieLinzess, Namzaric, Synthroid | $349 | $29,71262 claims |
| Johnson & JohnsonXarelto | $16 | $25,76625 claims |
| Astellas Pharma US IncMyrbetriq | $76 | $12,79820 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $83 | $7,87214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Moultrie
- Gary SwartzentruberMoultrie$38K
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.